Volume 11, Issue 1 (5-2024)                   J Jiroft Univ Med Sci 2024, 11(1): 1460-1470 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Begham M, Shabkhiz F, Shirvani H, Khalafi M. The Effect of Resistance Training and Nanocurcumin on Tumor Tissue Inflammatory Markers (NF-κB and IL-1α) in Rats with Glioblastoma Multiforme. J Jiroft Univ Med Sci 2024; 11 (1) :1460-1470
URL: http://journal.jmu.ac.ir/article-1-773-en.html
1- PhD Student of Exercise Physiology, Aras International Campus, University of Tehran, Tehran, Iran
2- Associate Professor, Exercise Physiology Department, Faculty of Sport Sciences and Health, University of Tehran, Tehran, Iran , shabkhiz@ut.ac.ir
3- Associate Professor of Exercise Physiology, Exercise Physiology Research Center, Lifestyle Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
4- Assistant Professor of Exercise Physiology, Department of Sports Sciences, Faculty of Humanities, University of Kashan, Kashan, Iran
Abstract:   (591 Views)
Introduction: The aim of this study was to investigate the effect of resistance training and nanocurcumin supplementation on protein amounts of NF-κB and IL-1α involved in tumor metabolism in rats with glioblastoma multiforme (GBM).
Materials and Methods:30 male Wistar rats were divided into 5 groups namely, healthy control, GBM, GBM+resistance training (RT), GBM+nanocurcumin supplement (NCUR), and GBM+RT+NCUR. GBM was injected into the frontal cortex of rats. The training group performed incremental resistance training on the ladder for 4 weeks, 3 days per week. At the end, the rats were sacrificed and the histological changes of the brain tumor were evaluated by H&E method, and also the expression of NF-κB and IL-1α protein were measured by western blot method.
Results: Compared to the healthy control group, the GBM group showed significant tissue changes (increasing tumor area) and increased IL-1α protein levels (p0/05). In the analysis of tissue changes, it was found that the GBM+RT, GBM+NCUR and GBM+RT+NCUR (p0/05) groups showed a significant reduction in the brain tumor area compared to the GBM group. Also, the GBM+RT+NCUR group showed a significant decrease in tumor area compared to the GBM+RT and GBM+NCUR groups (p0/05).
Conclusion: It seems that, to evaluate the changes of inflammatory markers involved in tumor metabolism, longer treatment duration, different dosage of supplements, different exercise training, intensity and volume of exercise training should be used. Also, the progress of the disease can be one of the factors affecting the non-change of the molecular factors of the present study.
Full-Text [PDF 860 kb]   (232 Downloads)    
Type of Study: Research | Subject: Medical Sciences / Physiology
Received: 2024/02/3 | Accepted: 2024/05/16 | Published: 2024/06/30

References
1. Inaba N, Kimura M, Fujioka K, Ikeda K, Somura H, Akiyoshi K, et al. The effect of PTEN on proliferation and drug-, and radiosensitivity in malignant glioma cells. Anticancer Research. 2011;31(5):1653-8.
2. Lötsch D, Steiner E, Holzmann K, Spiegl-Kreinecker S, Pirker C, Hlavaty J, et al. Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis. Oncotarget. 2013;4(11):1904. [DOI:10.18632/oncotarget.1264]
3. Afshari AR, Jalili-Nik M, Soukhtanloo M, Ghorbani A, Sadeghnia HR, Mollazadeh H, et al. Auraptene-induced cytotoxicity mechanisms in human malignant glioblastoma (U87) cells: role of reactive oxygen species (ROS). EXCLI Journal. 2019;18:576.
4. Murray PG, Flavell JR, Baumforth KR, Toomey S, Lowe D, Crocker J, et al. Expression of the tumour necrosis factor receptor associated factors 1 and 2 in Hodgkin's disease. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland. 2001;194(2):158-64. [DOI:10.1002/path.873]
5. Chiu JW, Binte Hanafi Z, Chew LCY, Mei Y, Liu H. IL-1α processing, signaling and its role in cancer progression. Cells. 2021;10(1):92. [DOI:10.3390/cells10010092]
6. McClellan JL, Steiner JL, Day SD, Enos RT, Davis MJ, Singh UP, et al. Exercise effects on polyp burden and immune markers in the ApcMin/+ mouse model of intestinal tumorigenesis. International Journal of Oncology. 2014;45(2):861-8. [DOI:10.3892/ijo.2014.2457]
7. Murphy EA, Davis JM, Barrilleaux T, McClellan J, Steiner J, Carmichael M, et al. Benefits of exercise training on breast cancer progression and inflammation in C3 (1) SV40Tag mice. Cytokine. 2011;55(2):274-9. [DOI:10.1016/j.cyto.2011.04.007]
8. Metsios GS, Moe RH, Kitas GD. Exercise and inflammation. Best Practice & Research Clinical Rheumatology. 2020;34(2):101504. [DOI:10.1016/j.berh.2020.101504]
9. Das Neves W, Alves CRR, de Almeida NR, Guimarães FLR, Ramires PR, Brum PC, et al. Loss of strength capacity is associated with mortality, but resistance exercise training promotes only modest effects during cachexia progression. Life Sciences. 2016;163:11-22. [DOI:10.1016/j.lfs.2016.08.025]
10. Deminice R, de Souza Padilha C, Borges F, da Silva LECM, Rosa FT, Robinson JL, et al. Resistance exercise prevents impaired homocysteine metabolism and hepatic redox capacity in Walker-256 tumor-bearing male Wistar rats. Nutrition. 2016;32(10):1153-8. [DOI:10.1016/j.nut.2016.03.008]
11. Aggarwal BB. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annual Review of Nutrition. 2010;30:173-99. [DOI:10.1146/annurev.nutr.012809.104755]
12. Heng MC. Curcumin targeted signaling pathways: basis for antiphotoaging and anticarcinogenic therapy. International Journal of Dermatology. 2010;49(6):608-22. [DOI:10.1111/j.1365-4632.2010.04468.x]
13. Sharma C, Kaur J, Shishodia S, Aggarwal BB, Ralhan R. Curcumin down regulates smokeless tobacco-induced NF-κB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology. 2006;228(1):1-15. [DOI:10.1016/j.tox.2006.07.027]
14. Yallapu MM, Maher DM, Sundram V, Bell MC, Jaggi M, Chauhan SC. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. Journal of Ovarian Research. 2010;3:1-12. [DOI:10.1186/1757-2215-3-11]
15. Swanson L. Brain maps: structure of the rat brain: Gulf Professional Publishing; 2004.
16. Luciano TF, Marques S, Pieri B, De Souza DR, Araújo L, Nesi R, et al. Responses of skeletal muscle hypertrophy in Wistar rats to different resistance exercise models. Physiological Research. 2017;66(2):317. [DOI:10.33549/physiolres.933256]
17. Vijayakurup V, Thulasidasan AT, Shankar G M, Retnakumari AP, Nandan CD, Somaraj J, et al. Chitosan encapsulation enhances the bioavailability and tissue retention of curcumin and improves its efficacy in preventing B [a] P-induced lung carcinogenesis. Cancer Prevention Research. 2019;12(4):225-36. [DOI:10.1158/1940-6207.CAPR-18-0437]
18. Wellington D, Mikaelian I, Singer L. Comparison of ketamine-xylazine and ketamine-dexmedetomidine anesthesia and intraperitoneal tolerance in rats. Journal of the American Association for Laboratory Animal Science. 2013;52(4):481-7.
19. Sharma B, Allison D, Tucker P, Mabbott D, Timmons BW. Exercise trials in pediatric brain tumor: A systematic review of randomized studies. Journal of Pediatric Hematology/Oncology. 2021;43(2):59-67. [DOI:10.1097/MPH.0000000000001844]
20. Olar A, Aldape KD. Using the molecular classification of glioblastoma to inform personalized treatment. The Journal of Pathology. 2014;232(2):165-77. [DOI:10.1002/path.4282]
21. Chahar MK, Sharma N, Dobhal MP, Joshi YC. Flavonoids: A versatile source of anticancer drugs. Pharmacognosy Reviews. 2011;5(9):1. [DOI:10.4103/0973-7847.79093]
22. Dützmann S, Schiborr C, Kocher A, Pilatus U, Hattingen E, Weissenberger J, et al. Intratumoral concentrations and effects of orally administered micellar curcuminoids in glioblastoma patients. Nutrition and Cancer. 2016;68(6):943-8. [DOI:10.1080/01635581.2016.1187281]
23. Chiu SS, Lui E, Majeed M, Vishwanatha JK, Ranjan AP, Maitra A, et al. Differential distribution of intravenous curcumin formulations in the rat brain. Anticancer Research. 2011;31(3):907-11.
24. Hardee JP, Porter RR, Sui X, Archer E, Lee I-M, Lavie CJ, et al., editors. The effect of resistance exercise on all-cause mortality in cancer survivors. Mayo Clinic Proceedings; 2014: 89(8):1108-15. [DOI:10.1016/j.mayocp.2014.03.018]
25. Sandler CX, Matsuyama M, Jones TL, Bashford J, Langbecker D, Hayes SC. Physical activity and exercise in adults diagnosed with primary brain cancer: a systematic review. Journal of Neuro-oncology. 2021;153:1-14. [DOI:10.1007/s11060-021-03745-3]
26. Pedersen BK, Saltin B. Exercise as medicine-evidence for prescribing exercise as therapy in 26 different chronic diseases. Scandinavian Journal of Medicine & Science in Sports. 2015;25:1-72. [DOI:10.1111/sms.12581]
27. Silveira LS, Batatinha HAP, Castoldi A, Câmara NOS, Festuccia WT, Souza CO, et al. Exercise rescues the immune response fine tuned impaired by peroxisome proliferator activated receptors γ deletion in macrophages. Journal of Cellular Physiology. 2019;234(4):5241-51. [DOI:10.1002/jcp.27333]
28. Padilha CS, Borges FH, Costa Mendes da Silva LE, Frajacomo FTT, Jordao AA, Duarte JA, et al. Resistance exercise attenuates skeletal muscle oxidative stress, systemic pro-inflammatory state, and cachexia in Walker-256 tumor-bearing rats. Applied Physiology, Nutrition, and Metabolism. 2017;42(9):916-23. [DOI:10.1139/apnm-2016-0436]
29. Krüger K, Bredehöft J, Mooren FC, Rummel C. Different effects of strength and endurance exercise training on COX-2 and mPGES expression in mouse brain are independent of peripheral inflammation. Journal of Applied Physiology. 2016;121(1):248-54. [DOI:10.1152/japplphysiol.00284.2016]
30. Hajinajaf S, Shirvani H, Roozbehani M, Khademi A. The effect of moderate-intensity continuous training and nanocurcumine supplementation on STAT3 gene expression in mice with glioblastoma multiforme brain tumor. Jundishapur Scientific Medical Journal. 2022;21(3).408-421. (In persian) [DOI:10.32598/JSMJ.21.3.2793]
31. Xia Y, Shen S, Verma IM. NF-κB, an active player in human cancers. Cancer Immunology Research. 2014;2(9):823-30. [DOI:10.1158/2326-6066.CIR-14-0112]
32. Tarassishin L, Lim J, Weatherly DB, Angeletti RH, Lee SC. Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression. Journal of Proteomics. 2014;99:152-68. [DOI:10.1016/j.jprot.2014.01.024]
33. Kalinski T, Sel S, Hütten H, Röpke M, Roessner A, Nass N. Curcumin blocks interleukin-1 signaling in chondrosarcoma cells. PLoS One. 2014;9(6):e99296. [DOI:10.1371/journal.pone.0099296]
34. Hatcher H, Planalp R, Cho J, Torti F, Torti S. Curcumin: from ancient medicine to current clinical trials. Cellular and Molecular Life Sciences. 2008;65:1631-52. [DOI:10.1007/s00018-008-7452-4]
35. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clinical Cancer Research. 2008;14(14):4491-9. [DOI:10.1158/1078-0432.CCR-08-0024]
36. Rajasekar, A. Facile synthesis of curcumin nanocrystals and validation of its antioxidant activity against circulatory toxicity in Wistar rats. Journal of Nanoscience and Nanotechnology. 2015, 15(6), 4119-4125 [DOI:10.1166/jnn.2015.9600]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Jiroft University of Medical Sciences

Designed & Developed by : Yektaweb